Position in MRNA
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$227,431
-$72,688 QoQ
Shares Held
4,477
-56.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CENTAURUS FINANCIAL, INC. holds $4,932,922 across 11 Biotechnology names. MRNA ranks #5 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
23,174 | $1,497,735 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,721 | $1,215,035 | |
| 3 | AUPH |
Aurinia Pharmaceuticals Inc.
|
61,020 | $904,316 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
709 | $371,140 | |
| 5 | MRNA |
Moderna, Inc.
This page
|
4,477 | $227,431 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,314 | $201,248 | |
| 7 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
7,249 | $179,485 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
195 | $150,664 |
All Filings in MRNA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $227,431 | 4,477 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $300,119 | 10,177 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $418,032 | 16,184 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $170,423 | 6,177 | Shares | Sole | 2025-08-29 | |
| 2025-03-31 | $176,110 | 6,212 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $261,413 | 6,287 | Shares | Sole | 2025-03-12 | |
| 2024-09-30 | $421,029 | 6,300 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $752,281 | 6,335 | Shares | Sole | 2024-09-23 | |
| 2024-03-31 | $739,846 | 6,943 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $704,404 | 7,083 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $709,499 | 6,869 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $842,845 | 6,937 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,304,201 | 8,492 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $1,519,046 | 8,457 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,047,695 | 8,860 | Shares | Sole | 2022-12-05 | |
| 2022-06-30 | $1,281,364 | 8,970 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $1,609,597 | 9,344 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,363,283 | 9,305 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $3,814,347 | 9,911 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,138,392 | 13,356 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $843,056 | 6,438 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $547,422 | 5,240 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $648,282 | 9,163 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $553,875 | 8,626 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $104,825 | 3,500 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||